Bio Blast Pharma reports promising data on muscle wasting drug

October 27, 2015 10:17 AM

30 0

Oct 27 Drug developer Bio Blast Pharma Ltd said its drug showed signs of being effective in treating patients with a rare muscle wasting disorder, according to interim results from a mid-stage study.

The company said its lead drug in development, Cabaletta, hit the main goal of proving to be safe and tolerable in the study on patient suffering from oculopharyngeal muscular dystrophy.

Also read: New Drug Combinations Improve Survival in Lung Cancer

Read more

To category page